Ubs Group Ag Exagen Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Exagen Inc. stock. As of the latest transaction made, Ubs Group Ag holds 90,011 shares of XGN stock, worth $814,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,011

Previous 446,207 79.83%

Holding current value

$814,599

Previous $3.11 Million 68.46%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$6.78 - $10.92 $2.42 Million - $3.89 Million	-356,196 Reduced 79.83%	90,011 $982,000
Q2 2025 Aug 14, 2025	BUY	$3.93 - $7.71 $1.51 Million - $2.96 Million	383,691 Added 613.75%	446,207 $3.11 Million
Q1 2025 May 13, 2025	SELL	$2.74 - $5.33 $4,660 - $9,066	-1,701 Reduced 2.65%	62,516 $224,000
Q4 2024 Feb 14, 2025	SELL	$2.43 - $6.0 $34,773 - $85,860	-14,310 Reduced 18.22%	64,217 $263,000
Q3 2024 Nov 14, 2024	BUY	$1.74 - $3.42 $27,859 - $54,757	16,011 Added 25.61%	78,527 $242,000

Q1 2024 May 13, 2024	BUY	$1.42 - $2.3 $151 - $246	107 Added 0.17%	62,516 $99,000
Q4 2023 Feb 09, 2024	SELL	$1.45 - $2.39 $99,214 - $163,533	-68,424 Reduced 52.3%	62,409 $124,000
Q1 2023 May 12, 2023	SELL	$2.23 - $2.9 $13,413 - $17,443	-6,015 Reduced 4.4%	130,833 $317,000
Q4 2022 Feb 08, 2023	BUY	$2.1 - $3.4 $73 - $119	35 Added 0.03%	136,848 $328,000
Q3 2022 Nov 10, 2022	BUY	$2.69 - $8.68 $13,837 - $44,649	5,144 Added 3.91%	136,813 $370,000
Q2 2022 Aug 10, 2022	SELL	$4.18 - $7.74 $1,245 - $2,306	-298 Reduced 0.23%	131,669 $756,000
Q1 2022 May 16, 2022	SELL	$7.12 - $11.06 $27,226 - $42,293	-3,824 Reduced 2.82%	131,967 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$8.97 - $14.08 $52,851 - $82,959	5,892 Added 4.54%	135,791 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$10.25 - $15.21 $6,949 - $10,312	678 Added 0.52%	129,899 $1.77 Million
Q2 2021 Aug 13, 2021	SELL	$12.4 - $17.92 $41,440 - $59,888	-3,342 Reduced 2.52%	129,221 $1.94 Million
Q1 2021 May 12, 2021	BUY	$13.9 - $22.0 $1.83 Million - $2.9 Million	131,703 Added 15314.3%	132,563 $2.32 Million
Q4 2020 Feb 11, 2021	BUY	$11.19 - $16.05 $9,119 - $13,080	815 Added 1811.11%	860 $11,000
Q3 2020 Nov 12, 2020	SELL	$10.56 - $16.69 $15,480 - $24,467	-1,466 Reduced 97.02%	45 $0
Q2 2020 Jul 31, 2020	SELL	$11.0 - $16.7 $4,565 - $6,930	-415 Reduced 21.55%	1,511 $19,000
Q1 2020 May 01, 2020	SELL	$12.7 - $25.95 $27,470 - $56,129	-2,163 Reduced 52.9%	1,926 $31,000
Q4 2019 Feb 14, 2020	BUY	$12.61 - $28.48 $51,562 - $116,454	4,089 New	4,089 $104,000

Others Institutions Holding XGN

# of Institutions

Shares Held

8.96M

Call Options Held

25.7K

Put Options Held

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $147M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account